{"id":"W3123856695","doi":"10.1200/jco.2021.39.3_suppl.230","title":"LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Internal medicine; Cancer; Response Evaluation Criteria in Solid Tumors; Oncology; Cohort; Phases of clinical research; Adverse effect; Gastroenterology; Surgery; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337805,0.0002276522,0.002254746,0.0001591825,0.00006045873,0.00001084195,0.0002446208,0.0001626104,0.0001570246],"category_scores_gemma":[0.00397851,0.0001322194,0.0002303988,0.0008842587,0.0001240943,0.0000950237,0.0001220505,0.0009855627,0.000001466364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003614848,"about_ca_system_score_gemma":0.002394759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00116984,"about_ca_topic_score_gemma":0.002942947,"domain_scores_codex":[0.9946011,0.0006303728,0.003350792,0.0003525746,0.0007232173,0.0003419787],"domain_scores_gemma":[0.9938923,0.001828301,0.002620719,0.0003587935,0.001079337,0.0002205519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03628011,0.01283649,0.9172413,0.00001466484,0.001437337,0.0006218471,0.0007924765,0.0002053751,0.00001149766,5.441314e-7,0.002034824,0.02852358],"study_design_scores_gemma":[0.1337051,0.03307315,0.8298945,0.000190756,0.001560247,0.00001811698,0.0004523993,0.000226872,0.00001667359,0.000002292592,0.0007668386,0.00009304826],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965685,0.0001956588,0.00001330694,0.001493317,0.000360158,0.001119243,0.00002969949,0.00001056526,0.0002095521],"genre_scores_gemma":[0.998053,0.0002752468,0.0002587892,0.0006220435,0.000408246,0.00002180073,0.00004162941,0.00002273739,0.0002965094],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09742498,"threshold_uncertainty_score":0.5391751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06305905101085445,"score_gpt":0.4187735071312949,"score_spread":0.3557144561204404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}